Cited by 32Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsMicroRNA in disease regulation

Protective Signature of IFNγ-Stimulated Microglia Relies on miR-124-3p Regulation From the Secretome Released by Mutant APP Swedish Neuronal Cells

Open access
Garcia, Gonçalo, Fernandes, Adelaide, Stein, Frank, Brites, Dora·2022·Frontiers in Pharmacology

Abstract

Microglia-associated inflammation and miRNA dysregulation are key players in Alzheimer’s disease (AD) pathophysiology. Previously, we showed miR-124 upregulation in APP Swedish SH-SY5Y (SWE) and PSEN1 iPSC-derived neurons and its propagation by the secretome (soluble and exosomal fractions). After modulation with miR-124 mimic/inhibitor, we identified common responsive mechanisms between such models. We also reported miR-124 colocalization with microglia in AD patient hippocampi. Herein, we determined how miR-124 modulation in SWE cells influences microglia polarized subtypes in the context of inflammation. We used a coculture system without cell-to-cell contact formed by miR-124 modulated SWE cells and human CHME3 microglia stimulated with interferon-gamma (IFNγ-MG), in which we assessed their adopted gene/miRNA profile and proteomic signature. The increase of miR-124 in SWE cells/secretome (soluble and exosomal) was mimicked in IFNγ-MG. Treatment of SWE cells with the miR-124 inhibitor led to RAGE overexpression and loss of neuronal viability, while the mimic caused RAGE/HMGB1 downregulation and prevented mitochondria membrane potential loss. When accessing the paracrine effects on microglia, SWE miR-124 inhibitor favored their IFNγ-induced inflammatory signature (upregulated RAGE/HMGB1/iNOS/IL-1β; downregulated IL-10/ARG-1), while the mimic reduced microglia activation (downregulated TNF-α/iNOS) and deactivated extracellular MMP-2/MMP-9 levels. Microglia proteomics identified 113 responsive proteins to SWE miR-124 levels, including a subgroup of 17 proteins involved in immune function/inflammation and/or miR-124 targets. A total of 72 proteins were downregulated (e.g., MAP2K6) and 21 upregulated (e.g., PAWR) by the mimic, while the inhibitor also upregulated 21 proteins and downregulated 17 (e.g., TGFB1, PAWR, and EFEMP1). Other targets were associated with neurodevelopmental mechanisms, synaptic function, and vesicular trafficking. To examine the source of miR-124 variations in microglia, we silenced the RNase III endonuclease Dicer1 to block miRNA canonical biogenesis. Despite this suppression, the coculture with SWE cells/exosomes still raised microglial miR-124 levels, evidencing miR-124 transfer from neurons to microglia. This study is pioneer in elucidating that neuronal miR-124 reshapes microglia plasticity and in revealing the relevance of neuronal survival in mechanisms underlying inflammation in AD-associated neurodegeneration. These novel insights pave the way for the application of miRNA-based neuropharmacological strategies in AD whenever miRNA dysregulated levels are identified during patient stratification.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2022.833066

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • miRNAs can be released by cells as free species directly into their secretome or selectively enriched in exosomes (diameter <150 nm) that, when internalized by target cells, affect their biological functions.

    “In general, miRNAs can be released by cells as free species directly into their secretome or selectively enriched in small extracellular vesicles (exosomes, diameter size <150 nm) that, when internalized by target cells, affect their biological functions [38,39,40,41].”

    From Emerging Role of miR-21-5p in Neuron–Glia Dysregulation and Exosome Transfer Using Multiple Models of Alzheimer’s Disease (2022) · cites this paper as [40]

    Results §3.1 reports miR-124 in both exosomes and exosome-free secretome, and Results §3.8 reports that miR-124-loaded exosomes are internalized by microglia and affect their function. However, Methods §2.4 defines the exosomes examined as 50–200 nm, not under 150 nm; the paper also describes exosome-free miRNAs as soluble without establishing that they are free, unbound species. Page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • SWE cell transplantation caused increased hippocampal microglial activation compared with non-transplanted or SH engraftment.

    “Here, we observed the efficient transplantation of SWE cells, which caused increased hippocampal microglial activation when compared to non-transplanted or SH engraftment, further confirming our previous studies centered on the paracrine influence of SWE cells on microglial activation [39,40].”
  • miR-21 is upregulated in SWE cells and in iPSC-derived neurons from patients with the PSEN1 mutation.

    “Our previously published data have shown the upregulation of miR-21 in SWE cells and in iPSC-derived neurons from patients with the PSEN1 mutation [25,39,40].”

    From Emerging Role of miR-21-5p in Neuron–Glia Dysregulation and Exosome Transfer Using Multiple Models of Alzheimer’s Disease (2022) · cites this paper as [40]

    The Results (section 3.1) report upregulation of miR-124 in SWE cells, not miR-21. The Discussion mentions miR-21 only as a predicted contributor of interest for future study, and the passages found do not report miR-21 levels in PSEN1-mutant iPSC-derived neurons (searched: miR-21, PSEN1 mutation, iPSC-derived neurons). (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 100

  1. Abbas N. Bednar I. Mix E. Marie S. Paterson D. Ljungberg A. (2002). Up-regulation of the Inflammatory Cytokines IFN-Gamma and IL-12 and Down-Regulation of IL-4 in Cerebral Cortex Regions of APP(SWE) Transgenic Mice. J. Neuroimmunol. 126, 50– 57. 10.1016/S0165-5728(02)00050-4 12020956 · DOI
  2. Ahuja S. Lazar I. M. (2021). Systems-Level Proteomics Evaluation of Microglia Response to Tumor-Supportive Anti-inflammatory Cytokines. Front. Immunol. 12, 3404. 10.3389/fimmu.2021.646043 PMC8458581 34566949 · DOI
  3. An F. Gong G. Wang Y. Bian M. Yu L. Wei C. (2017). MiR-124 Acts as a Target for Alzheimer's Disease by Regulating BACE1. Oncotarget 8, 114065– 114071. 10.18632/oncotarget.23119 29371969 PMC5768386 · DOI
  4. Ansari A. Maffioletti E. Milanesi E. Marizzoni M. Frisoni G. B. Blin O. (2019). miR-146a and miR-181a Are Involved in the Progression of Mild Cognitive Impairment to Alzheimer's Disease. Neurobiol. Aging 82, 102– 109. 10.1016/j.neurobiolaging.2019.06.005 31437718 · DOI
  5. Bachiller S. Jiménez-Ferrer I. Paulus A. Yang Y. Swanberg M. Deierborg T. (2018). Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Front. Cel. Neurosci. 12, 488. 10.3389/fncel.2018.00488 PMC6305407 30618635 · DOI
  6. Baglietto-Vargas D. Forner S. Cai L. Martini A. C. Trujillo-Estrada L. Swarup V. (2021). Generation of a Humanized Aβ Expressing Mouse Demonstrating Aspects of Alzheimer's Disease-like Pathology. Nat. Commun. 12, 2421. 10.1038/s41467-021-22624-z 33893290 PMC8065162 · DOI
  7. Bal-Price A. Brown G. C. (2001). Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity. J. Neurosci. 21, 6480– 6491. 10.1523/jneurosci.21-17-06480.2001 11517237 PMC6763071 · DOI · Paper page
  8. Baxter P. S. Dando O. Emelianova K. He X. McKay S. Hardingham G. E. (2021). Microglial Identity and Inflammatory Responses Are Controlled by the Combined Effects of Neurons and Astrocytes. Cell Rep 34, 108882. 10.1016/j.celrep.2021.108882 33761343 PMC7994374 · DOI · Paper page
  9. Belkhelfa M. Rafa H. Medjeber O. Arroul-Lammali A. Behairi N. Abada-Bendib M. (2014). IFN-γ and TNF-α Are Involved during Alzheimer Disease Progression and Correlate with Nitric Oxide Production: a Study in Algerian Patients. J. Interferon Cytokine Res. 34, 839– 847. 10.1089/jir.2013.0085 24831467 · DOI
  10. Bell E. Taylor M. A. (2016). Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment. Comput. Struct. Biotechnol. J. 15, 8– 13. 10.1016/j.csbj.2016.10.005 27872688 PMC5109280 · DOI
  11. Belyaev N. D. Kellett K. A. Beckett C. Makova N. Z. Revett T. J. Nalivaeva N. N. (2010). The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a {beta}-secretase-dependent Pathway. J. Biol. Chem. 285, 41443– 41454. 10.1074/jbc.M110.141390 20961856 PMC3009870 · DOI
  12. Brioschi S. d'Errico P. Amann L. S. Janova H. Wojcik S. M. Meyer-Luehmann M. (2020). Detection of Synaptic Proteins in Microglia by Flow Cytometry. Front. Mol. Neurosci. 13, 149. 10.3389/fnmol.2020.00149 33132837 PMC7550663 · DOI
  13. Brites D. (2020). Regulatory Function of microRNAs in Microglia. Glia 68, 1631– 1642. 10.1002/glia.23846 32463968 · DOI
  14. Chakraborty M. Qiu S. G. Vasudevan K. M. Rangnekar V. M. Rangnekar V. M. Rangnekar V. M. (2001). Par-4 Drives Trafficking and Activation of Fas and FasL to Induce Prostate Cancer Cell Apoptosis and Tumor Regression. Cancer Res. 61, 7255– 7263. 11585763
  15. Chang L. Zhou G. Soufan O. Xia J. (2020). miRNet 2.0: Network-Based Visual Analytics for miRNA Functional Analysis and Systems Biology. Nucleic Acids Res. 48, W244– W251. 10.1093/nar/gkaa467 32484539 PMC7319552 · DOI
  16. Chen X. Guo C. Kong J. (2012). Oxidative Stress in Neurodegenerative Diseases. Neural Regen. Res. 7, 376– 385. 10.3969/j.issn.1673-5374.2012.05.009 25774178 PMC4350122 · DOI
  17. Chien C. H. Lee M. J. Liou H. C. Liou H. H. Fu W. M. (2016). Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice. PLoS One 11, e0151569. 10.1371/journal.pone.0151569 26982707 PMC4794203 · DOI
  18. Choi Y. J. Kim S. Choi Y. Nielsen T. B. Yan J. Lu A. (2019). SERPINB1-mediated Checkpoint of Inflammatory Caspase Activation. Nat. Immunol. 20, 276– 287. 10.1038/s41590-018-0303-z 30692621 PMC6450391 · DOI
  19. Coles L. S. Diamond P. Occhiodoro F. Vadas M. A. Shannon M. F. (1996). Cold Shock Domain Proteins Repress Transcription from the GM-CSF Promoter. Nucleic Acids Res. 24, 2311– 2317. 10.1093/nar/24.12.2311 8710501 PMC145951 · DOI
  20. Cunha C. Gomes C. Vaz A. R. Brites D. (2016). Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization. Mediators Inflamm. 2016, 6986175. 10.1155/2016/6986175 28096568 PMC5209629 · DOI · Paper page
  21. de Abreu R. C. Ramos C. V. Becher C. Lino M. Jesus C. da Costa Martins P. A. (2021). Exogenous Loading of miRNAs into Small Extracellular Vesicles. J. Extracell. Vesicles 10, e12111. 10.1002/jev2.12111 34377372 PMC8329988 · DOI
  22. Dello Russo C. Cappoli N. Coletta I. Mezzogori D. Paciello F. Pozzoli G. (2018). The Human Microglial HMC3 Cell Line: where Do We Stand? A Systematic Literature Review. J. Neuroinflammation 15, 259. 10.1186/S12974-018-1288-0 30200996 PMC6131758 · DOI
  23. Eitan E. Hutchison E. R. Marosi K. Comotto J. Mustapic M. Nigam S. M. (2016). Extracellular Vesicle-Associated Aβ Mediates Trans-neuronal Bioenergetic and Ca2+-Handling Deficits in Alzheimer's Disease Models. Npj Aging Mech. Dis. 2, 16019. 10.1038/npjamd.2016.19 27928512 PMC5137253 · DOI · Paper page
  24. Fan Z. Brooks D. J. Okello A. Edison P. (2017). An Early and Late Peak in Microglial Activation in Alzheimer's Disease Trajectory. Brain 140, 792– 803. 10.1093/brain/aww349 28122877 PMC5837520 · DOI
  25. Fernandes A. Ribeiro A. R. Monteiro M. Garcia G. Vaz A. R. Brites D. (2018). Secretome from SH-Sy5y APPSwe Cells Trigger Time-dependent CHME3 Microglia Activation Phenotypes, Ultimately Leading to miR-21 Exosome Shuttling. Biochimie 155, 67– 82. 10.1016/J.BIOCHI.2018.05.015 29857185 · DOI · Paper page
  26. Franken H. Mathieson T. Childs D. Sweetman G. M. Werner T. Tögel I. (2015). Thermal Proteome Profiling for Unbiased Identification of Direct and Indirect Drug Targets Using Multiplexed Quantitative Mass Spectrometry. Nat. Protoc. 10, 1567– 1593. 10.1038/nprot.2015.101 26379230 · DOI
  27. Fumagalli M. Lombardi M. Gressens P. Verderio C. (2018). How to Reprogram Microglia toward Beneficial Functions. Glia 66, 2531– 2549. 10.1002/glia.23484 30195261 PMC6585737 · DOI
  28. Garcia G. Pinto S. Cunha M. Fernandes A. Koistinaho J. Brites D. (2021). Neuronal Dynamics and miRNA Signaling Differ between SH-Sy5y APPSwe and PSEN1 Mutant iPSC-Derived AD Models upon Modulation with miR-124 Mimic and Inhibitor. Cells 10, 2424. 10.3390/cells10092424 34572073 PMC8465877 · DOI · Paper page
  29. Garner K. M. Amin R. Johnson R. W. Scarlett E. J. Burton M. D. (2018). Microglia Priming by Interleukin-6 Signaling Is Enhanced in Aged Mice. J. Neuroimmunol. 324, 90– 99. 10.1016/j.jneuroim.2018.09.002 30261355 PMC6699492 · DOI
  30. Greco I. Day N. Riddoch-Contreras J. Reed J. Soininen H. Kłoszewska I. (2012). Alzheimer's Disease Biomarker Discovery Using In Silico Literature Mining and Clinical Validation. J. Transl Med. 10. 10.1186/1479-5876-10-217 PMC3508881 23113945 · DOI
  31. Han D. Dong X. Zheng D. Nao J. (2020). MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders. Front. Pharmacol. 10, 1555. 10.3389/fphar.2019.01555 32009959 PMC6978711 · DOI · Paper page
  32. Hartmann H. Hoehne K. Rist E. Louw A. M. Schlosshauer B. (2015). miR-124 Disinhibits Neurite Outgrowth in an Inflammatory Environment. Cell Tissue Res 362, 9– 20. 10.1007/s00441-015-2183-y 25920589 · DOI
  33. Hatziapostolou M. Polytarchou C. Aggelidou E. Drakaki A. Poultsides G. A. Jaeger S. A. (2011). An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis. Cell 147, 1233– 1247. 10.1016/j.cell.2011.10.043 22153071 PMC3251960 · DOI
  34. Hernandez-Guillamon M. Mawhirt S. Blais S. Montaner J. Neubert T. A. Rostagno A. (2015). Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9. J. Biol. Chem. 290, 15078– 15091. 10.1074/jbc.M114.610931 25897080 PMC4463451 · DOI
  35. Hu Z. Li Z. (2017). miRNAs in Synapse Development and Synaptic Plasticity. Curr. Opin. Neurobiol. 45, 24– 31. 10.1016/J.CONB.2017.02.014 28334640 PMC5554733 · DOI
  36. Huber W. von Heydebreck A. Sültmann H. Poustka A. Vingron M. (2002). Variance Stabilization Applied to Microarray Data Calibration and to the Quantification of Differential Expression. Bioinformatics 18, S96– S104. 10.1093/bioinformatics/18.suppl_1.S96 12169536 · DOI · Paper page
  37. Hughes C. S. Foehr S. Garfield D. A. Furlong E. E. Steinmetz L. M. Krijgsveld J. (2014). Ultrasensitive Proteome Analysis Using Paramagnetic Bead Technology. Mol. Syst. Biol. 10, 757. 10.15252/msb.20145625 25358341 PMC4299378 · DOI
  38. Janabi N. Peudenier S. Héron B. Ng K. H. Tardieu M. (1995). Establishment of Human Microglial Cell Lines after Transfection of Primary Cultures of Embryonic Microglial Cells with the SV40 Large T Antigen. Neurosci. Lett. 195, 105– 108. 10.1016/0304-3940(94)11792-H 7478261 · DOI · Paper page
  39. Jiang D. Gong F. Ge X. Lv C. Huang C. Feng S. (2020). Neuron-derived Exosomes-Transmitted miR-124-3p Protect Traumatically Injured Spinal Cord by Suppressing the Activation of Neurotoxic Microglia and Astrocytes. J. Nanobiotechnology 18, 105. 10.1186/s12951-020-00665-8 32711535 PMC7382861 · DOI · Paper page
  40. Khoonsari P. E. Häggmark A. Lönnberg M. Mikus M. Kilander L. Lannfelt L. (2016). Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease. PLoS One 11, e0150672. 10.1371/journal.pone.0150672 26950848 PMC4780771 · DOI
  41. Ko C. Y. Chang W. C. Wang J. M. (2015). Biological Roles of CCAAT/Enhancer-binding Protein delta during Inflammation. J. Biomed. Sci. 22, 6. 10.1186/s12929-014-0110-2 25591788 PMC4318212 · DOI
  42. Könnecke H. Bechmann I. (20132013). The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas. Clin. Developmental Immunol. 2013, 1– 15. 10.1155/2013/914104 PMC3759277 24023566 · DOI
  43. Korecka J. A. van Kesteren R. E. Blaas E. Spitzer S. O. Kamstra J. H. Smit A. B. (2013). Phenotypic Characterization of Retinoic Acid Differentiated SH-Sy5y Cells by Transcriptional Profiling. PLoS One 8, e63862. 10.1371/journal.pone.0063862 23724009 PMC3665836 · DOI
  44. Kumar S. Reddy P. H. (2018). MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update. Front. Aging Neurosci. 10, 41. 10.3389/FNAGI.2018.00041 29527164 PMC5829054 · DOI
  45. Le Bras A. (2021). A New Mouse Model to Study Late-Onset Alzheimer's Disease. Lab. Anim. 50, 151. 10.1038/s41684-021-00780-5 · DOI
  46. Lee S. T. Im W. Ban J. J. Lee M. Jung K. H. Lee S. K. (2017). Exosome-Based Delivery of miR-124 in a Huntington's Disease Model. J. Mov. Disord. 10, 45– 52. 10.14802/jmd.16054 28122430 PMC5288667 · DOI · Paper page
  47. Leng F. Edison P. (2021). Neuroinflammation and Microglial Activation in Alzheimer Disease: where Do We Go from Here? Nat. Rev. Neurol. 17, 157– 172. 10.1038/s41582-020-00435-y 33318676 · DOI · Paper page
  48. Lu Y. Zhang T. Shan S. Wang S. Bian W. Ren T. (2019). MiR-124 Regulates Transforming Growth Factor-Β1 Induced Differentiation of Lung Resident Mesenchymal Stem Cells to Myofibroblast by Repressing Wnt/β-Catenin Signaling. Dev. Biol. 449, 115– 121. 10.1016/j.ydbio.2019.02.010 30802451 · DOI
  49. Mander P. Brown G. C. (2005). Activation of Microglial NADPH Oxidase Is Synergistic with Glial iNOS Expression in Inducing Neuronal Death: a Dual-Key Mechanism of Inflammatory Neurodegeneration. J. Neuroinflammation 2, 20. 10.1186/1742-2094-2-20 16156895 PMC1232863 · DOI
  50. Mastrangelo M. A. Sudol K. L. Narrow W. C. Bowers W. J. (2009). Interferon-{gamma} Differentially Affects Alzheimer's Disease Pathologies and Induces Neurogenesis in Triple Transgenic-AD Mice. Am. J. Pathol. 175, 2076– 2088. 10.2353/AJPATH.2009.090059 19808651 PMC2774071 · DOI · Paper page
  51. McGowan H. Mirabella V. R. Hamod A. Karakhanyan A. Mlynaryk N. Moore J. C. (2018). hsa-let-7c miRNA Regulates Synaptic and Neuronal Function in Human Neurons. Front. Synaptic Neurosci. 10, 19. 10.3389/FNSYN.2018.00019 30065644 PMC6056636 · DOI
  52. Meda L. Cassatella M. A. Szendrei G. I. Otvos L. Baron P. Villalba M. (1995). Activation of Microglial Cells by β-amyloid Protein and Interferon-γ. Nature 374, 647– 650. 10.1038/374647a0 7715705 · DOI · Paper page
  53. Mi H. Ebert D. Muruganujan A. Mills C. Albou L. P. Mushayamaha T. (2021). PANTHER Version 16: A Revised Family Classification, Tree-Based Classification Tool, Enhancer Regions and Extensive API. Nucleic Acids Res. 49, D394– D403. 10.1093/nar/gkaa1106 33290554 PMC7778891 · DOI
  54. Moggridge S. Sorensen P. H. Morin G. B. Hughes C. S. (2018). Extending the Compatibility of the SP3 Paramagnetic Bead Processing Approach for Proteomics. J. Proteome Res. 17, 1730– 1740. 10.1021/acs.jproteome.7b00913 29565595 · DOI
  55. Mühl H. Pfeilschifter J. (2003). Anti-inflammatory Properties of Pro-inflammatory Interferon-γ. Int. Immunopharmacol. 3, 1247– 1255. 10.1016/S1567-5769(03)00131-0 12890422 · DOI
  56. Müller I. I. Chatterjee M. Schneider M. Borst O. Seizer P. Schönberger T. (2014). Gremlin-1 Inhibits Macrophage Migration Inhibitory Factor-dependent Monocyte Function and Survival. Int. J. Cardiol. 176, 923– 929. 10.1016/j.ijcard.2014.08.051 25194861 · DOI
  57. Munir J. Yoon J. K. Ryu S. (2020). Therapeutic miRNA-Enriched Extracellular Vesicles: Current Approaches and Future Prospects. Cells 9, 2271. 10.3390/cells9102271 PMC7601381 33050562 · DOI
  58. Pan H. C. Yang C. N. Hung Y. W. Lee W. J. Tien H. R. Shen C. C. (2013). Reciprocal Modulation of C/EBP-α and C/EBP-β by IL-13 in Activated Microglia Prevents Neuronal Death. Eur. J. Immunol. 43, 2854– 2865. 10.1002/eji.201343301 23881867 · DOI
  59. Paolicelli R. C. Bolasco G. Pagani F. Maggi L. Scianni M. Panzanelli P. (2011). Synaptic Pruning by Microglia Is Necessary for normal Brain Development. Science 333, 1456– 1458. 10.1126/science.1202529 21778362 · DOI · Paper page
  60. Perez-Riverol Y. Csordas A. Bai J. Bernal-Llinares M. Hewapathirana S. Kundu D. J. (2019). The PRIDE Database and Related Tools and Resources in 2019: Improving Support for Quantification Data. Nucleic Acids Res. 47, D442– D450. 10.1093/nar/gky1106 30395289 PMC6323896 · DOI
  61. Phatnani H. P. Guarnieri P. Friedman B. A. Carrasco M. A. Muratet M. O'Keeffe S. (2013). Intricate Interplay between Astrocytes and Motor Neurons in ALS. Proc. Natl. Acad. Sci. U S A. 110, E756– E765. 10.1073/pnas.1222361110 23388633 PMC3581928 · DOI
  62. Pinto S. Cunha C. Barbosa M. Vaz A. R. Brites D. (2017). Exosomes from NSC-34 Cells Transfected with hSOD1-G93a Are Enriched in Mir-124 and Drive Alterations in Microglia Phenotype. Front. Neurosci. 11, 273. 10.3389/fnins.2017.00273 28567000 PMC5434170 · DOI · Paper page
  63. Pomeshchik Y. Klementieva O. Gil J. Martinsson I. Hansen M. G. de Vries T. (2020). Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-specific Cellular Phenotypes and Developing Therapies. Stem Cel Rep. 15, 256– 273. 10.1016/j.stemcr.2020.06.001 PMC7363942 32589876 · DOI · Paper page
  64. Ringland C. Schweig J. E. Eisenbaum M. Paris D. Ait-Ghezala G. Mullan M. (2021). MMP9 Modulation Improves Specific Neurobehavioral Deficits in a Mouse Model of Alzheimer's Disease. BMC Neurosci. 22, 39. 10.1186/s12868-021-00643-2 34034683 PMC8152085 · DOI
  65. Rock R. B. Hu S. Deshpande A. Munir S. May B. J. Baker C. A. (2005). Transcriptional Response of Human Microglial Cells to Interferon-Gamma. Genes Immun. 6, 712– 719. 10.1038/sj.gene.6364246 16163375 · DOI
  66. Saito Y. Saito H. (2012). MicroRNAs in Cancers and Neurodegenerative Disorders. Front. Genet. 3, 194. 10.3389/fgene.2012.00194 23056009 PMC3458258 · DOI
  67. Savitski M. M. Wilhelm M. Hahne H. Kuster B. Bantscheff M. (2015). A Scalable Approach for Protein False Discovery Rate Estimation in Large Proteomic Data Sets. Mol. Cel. Proteomics 14, 2394– 2404. 10.1074/mcp.M114.046995 PMC4563723 25987413 · DOI
  68. Schindelin J. Arganda-Carreras I. Frise E. Kaynig V. Longair M. Pietzsch T. (2012). Fiji: An Open-Source Platform for Biological-Image Analysis. Nat. Methods 9, 676– 682. 10.1038/nmeth.2019 22743772 PMC3855844 · DOI · Paper page
  69. Shirazi S. Huang C.-C. Kang M. Lu Y. Ravindran S. Cooper L. F. (2021). The Importance of Cellular and Exosomal miRNAs in Mesenchymal Stem Cell Osteoblastic Differentiation. Sci. Rep. 11, 1– 14. 10.1038/s41598-021-85306-2 33723364 PMC7960990 · DOI
  70. Silva S. L. Osório C. Vaz A. R. Barateiro A. Falcão A. S. Silva R. F. (2011). Dynamics of Neuron-Glia Interplay upon Exposure to Unconjugated Bilirubin. J. Neurochem. 117, 412– 424. 10.1111/j.1471-4159.2011.07200.x 21275990 · DOI
  71. Sonntag K. C. Woo T. U. Krichevsky A. M. (2012). Converging miRNA Functions in Diverse Brain Disorders: A Case for miR-124 and miR-126. Exp. Neurol. 235, 427– 435. 10.1016/j.expneurol.2011.11.035 22178324 PMC3335933 · DOI
  72. Spencer N. G. Schilling T. Miralles F. Eder C. (2016). Mechanisms Underlying Interferon-γ-Induced Priming of Microglial Reactive Oxygen Species Production. PLoS One 11, e0162497. 10.1371/journal.pone.0162497 27598576 PMC5012572 · DOI
  73. Svensson L. Howarth K. McDowall A. Patzak I. Evans R. Ussar S. (2009). Leukocyte Adhesion Deficiency-III Is Caused by Mutations in KINDLIN3 Affecting Integrin Activation. Nat. Med. 15, 306– 312. 10.1038/nm.1931 19234463 PMC2680140 · DOI
  74. Svoboda D. S. Barrasa M. I. Shu J. Rietjens R. Zhang S. Mitalipova M. (2019). Human iPSC-Derived Microglia Assume a Primary Microglia-like State after Transplantation into the Neonatal Mouse Brain. Proc. Natl. Acad. Sci. U S A. 116, 25293– 25303. 10.1073/pnas.1913541116 31772018 PMC6911218 · DOI
  75. Ta T. T. Dikmen H. O. Schilling S. Chausse B. Lewen A. Hollnagel J. O. (2019). Priming of Microglia with IFN-γ Slows Neuronal Gamma Oscillations In Situ. Proc. Natl. Acad. Sci. U. S. A. 116, 4637– 4642. 10.1073/pnas.1813562116 30782788 PMC6410786 · DOI
  76. Uriarte Huarte O. Richart L. Mittelbronn M. Michelucci A. (2021). Microglia in Health and Disease: The Strength to Be Diverse and Reactive. Front. Cel. Neurosci. 15, 107. 10.3389/fncel.2021.660523 PMC8044310 33867943 · DOI
  77. Veremeyko T. Kuznetsova I. S. Dukhinova M. W Y Yung A. Kopeikina E. Barteneva N. S. (2019). Neuronal Extracellular microRNAs miR-124 and miR-9 Mediate Cell-Cell Communication between Neurons and Microglia. J. Neurosci. Res. 97, 162– 184. 10.1002/jnr.24344 30367726 PMC6587827 · DOI
  78. Vitek M. P. Araujo J. A. Fossel M. Greenberg B. D. Howell G. R. Rizzo S. J. S. (2020). Translational Animal Models for Alzheimer's Disease: An Alzheimer's Association Business Consortium Think Tank. A&d Transl Res. Clin. Interv. 6, e12114. 10.1002/trc2.12114 PMC7798310 33457489 · DOI · Paper page
  79. von Bernhardi R. Eugenín-von Bernhardi L. Eugenín J. (2015). Microglial Cell Dysregulation in Brain Aging and Neurodegeneration. Front. Aging Neurosci. 7, 124. 10.3389/fnagi.2015.00124 26257642 PMC4507468 · DOI · Paper page
  80. Vukovic J. Ruitenberg M. J. Roet K. Franssen E. Arulpragasam A. Sasaki T. (2009). The Glycoprotein Fibulin-3 Regulates Morphology and Motility of Olfactory Ensheathing Cells In Vitro. Glia 57, 424– 443. 10.1002/glia.20771 18803302 · DOI
  81. Wang G. Huang Y. Wang L. L. Zhang Y. F. Xu J. Zhou Y. (2016). MicroRNA-146a Suppresses ROCK1 Allowing Hyperphosphorylation of Tau in Alzheimer's Disease. Sci. Rep. 6, 26697. 10.1038/srep26697 27221467 PMC4879631 · DOI
  82. Wang L. Deng W. Shi T. Ma D. (2008). URP2SF, a FERM and PH Domain Containing Protein, Regulates NF-kappaB and Apoptosis. Biochem. Biophys. Res. Commun. 368, 899– 906. 10.1016/j.bbrc.2008.02.024 18280249 · DOI
  83. Wang X. Liu D. Huang H. Z. Wang Z. H. Hou T. Y. Yang X. (2018). A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer's Disease. Biol. Psychiatry 83, 395– 405. 10.1016/j.biopsych.2017.07.023 28965984 · DOI
  84. Wang X.-X. Tan M.-S. Yu J.-T. Tan L. (2014). Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease. Biomed. Res. Int. 2014, 1– 8. 10.1155/2014/908636 PMC4094696 25050378 · DOI
  85. Wasilewski D. Villalba-Moreno N. D. Stange I. Glatzel M. Sepulveda-Falla D. Krasemann S. (2022). Reactive Astrocytes Contribute to Alzheimer's Disease-Related Neurotoxicity and Synaptotoxicity in a Neuron-Astrocyte Co-culture Assay. Front. Cel. Neurosci. 15, 540. 10.3389/fncel.2021.739411 PMC8813976 35126055 · DOI
  86. West P. K. Viengkhou B. Campbell I. L. Hofer M. J. (2019). Microglia Responses to Interleukin-6 and Type I Interferons in Neuroinflammatory Disease. Glia 67, 1821– 1841. 10.1002/glia.23634 31033014 · DOI
  87. Xie J. Guo Q. (2005). PAR-4 Is Involved in Regulation of Beta-Secretase Cleavage of the Alzheimer Amyloid Precursor Protein. J. Biol. Chem. 280, 13824– 13832. 10.1074/jbc.M411933200 15671026 · DOI
  88. Xu X. Li S. Lin Y. Chen H. Hu Z. Mao Y. (2013). MicroRNA-124-3p Inhibits Cell Migration and Invasion in Bladder Cancer Cells by Targeting ROCK1. J. Transl. Med. 11, 276. 10.1186/1479-5876-11-276 24180482 PMC4228407 · DOI
  89. Xu Z. Zhang K. Wang Q. Zheng Y. (2019). MicroRNA-124 I-mproves F-unctional R-ecovery and S-uppresses Bax-dependent A-poptosis in R-ats F-ollowing S-pinal C-ord I-njury. Mol. Med. Rep. 19, 2551– 2560. 10.3892/mmr.2019.9904 30720072 PMC6423616 · DOI
  90. Xue Q. Yu C. Wang Y. Liu L. Zhang K. Fang C. (2016). miR-9 and miR-124 Synergistically Affect Regulation of Dendritic Branching via the AKT/GSK3β Pathway by Targeting Rap2a. Sci. Rep. 6, 26781. 10.1038/srep26781 27221778 PMC4879704 · DOI
  91. Yang J. Zhang X. Chen X. Wang L. Yang G. (2017). Exosome Mediated Delivery of miR-124 Promotes Neurogenesis after Ischemia. Mol. Ther. Nucleic Acids 7, 278– 287. 10.1016/j.omtn.2017.04.010 28624203 PMC5415550 · DOI
  92. Yang K. Shen J. Chen S. W. Qin J. Zheng X. Y. Xie L. P. (2016). Upregulation of PAWR by Small Activating RNAs Induces Cell Apoptosis in Human Prostate Cancer Cells. Oncol. Rep. 35, 2487– 2493. 10.3892/or.2016.4582 26797252 · DOI
  93. Yang Y. Ye Y. Kong C. Su X. Zhang X. Bai W. (2019). MiR-124 Enriched Exosomes Promoted the M2 Polarization of Microglia and Enhanced Hippocampus Neurogenesis after Traumatic Brain Injury by Inhibiting TLR4 Pathway. Neurochem. Res. 44, 811– 828. 10.1007/s11064-018-02714-z 30628018 · DOI
  94. Yardeni T. Fine R. Joshi Y. Gradus-Pery T. Kozer N. Reichenstein I. (2018). High Content Image Analysis Reveals Function of miR-124 Upstream of Vimentin in Regulating Motor Neuron Mitochondria. Sci. Rep. 8, 59. 10.1038/s41598-017-17878-x 29311649 PMC5758812 · DOI
  95. Yu A. Zhang T. Duan H. Pan Y. Zhang X. Yang G. (2017). MiR-124 Contributes to M2 Polarization of Microglia and Confers Brain Inflammatory protection via the C/EBP-α Pathway in Intracerebral Hemorrhage. Immunol. Lett. 182, 1– 11. 10.1016/j.imlet.2016.12.003 28025043 · DOI
  96. Yu J. Y. Chung K. H. Deo M. Thompson R. C. Turner D. L. (2008). MicroRNA miR-124 Regulates Neurite Outgrowth during Neuronal Differentiation. Exp. Cel Res. 314, 2618– 2633. 10.1016/j.yexcr.2008.06.002 PMC2702206 18619591 · DOI
  97. Yuyama K. Igarashi Y. (2017). Exosomes as Carriers of Alzheimer's Amyloid-SS. Front. Neurosci. 11, 229. 10.3389/fnins.2017.00229 28487629 PMC5403946 · DOI
  98. Zarrouk A. Vejux A. Nury T. El Hajj H. I. Haddad M. Cherkaoui-Malki M. (2012). Induction of Mitochondrial Changes Associated with Oxidative Stress on Very Long Chain Fatty Acids (C22:0, C24:0, or C26:0)-Treated Human Neuronal Cells (SK-NB-E). Oxidative Med. Cell Longevity 2012, 623257. 10.1155/2012/623257 PMC3420217 22919440 · DOI
  99. Zheng D. Huo M. Li B. Wang W. Piao H. Wang Y. (2021). The Role of Exosomes and Exosomal MicroRNA in Cardiovascular Disease. Front. Cel Dev. Biol. 8, 1810. 10.3389/FCELL.2020.616161 PMC7835482 33511124 · DOI
  100. Zhu X. Rottkamp C. A. Hartzler A. Sun Z. Takeda A. Boux H. (2001). Activation of MKK6, an Upstream Activator of P38, in Alzheimer's Disease. J. Neurochem. 79, 311– 318. 10.1046/j.1471-4159.2001.00597.x 11677259 · DOI

Cited by

Sorted by citations

Authors
Garcia, G., Fernandes, A., Stein, F., & Brites, D.
Affiliations
  • University of Lisbon (PT)
  • European Molecular Biology Laboratory (DE)
Corresponding author
Brites, Dora
Venue
Frontiers in Pharmacology
Published
2022-05-10
Volume
13
Pages
833066-833066
ISSN
1663-9812 (ISSN-L)
OpenAlex
W4229455671
Cited by
32
References
13
Citations by year
2026: 10 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 5
FWCI
1.93
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • International Business Machines Corporation
  • Universidade de Lisboa (UIDB/04138/2020, UIDP/04138/2020)
  • Universidade do Porto
  • Fundação para a Ciência e a Tecnologia (01-0145, 04138, UIDB/04138, LISBOA‐01‐0145‐FEDER‐031395, UID/DTP/04138/2019, /2017, UIDB/04138/2020, JPCOFUND/0003/2015, SFRH/BD/128738/2017, UIDP/04138/2020, PTDC/MED-NEU/2382/2021, LISBOA-01-0145-FEDER)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Keywords
miR-124-3p, Alzheimer's disease, microglia, interferon-gamma, exosomes, microglial polarization, neuroinflammation, RAGE, HMGB1, paracrine signaling, MAP2K6, PAWR, TGF-β1, EFEMP1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review